2Anthonisen NR,Manfreda J,Warren CPW,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.Ann Intern Med,1987,106(2):196-204.
3Celli BR,MacNee W,Agusti A,et al.Standards for diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23(6):932-946.
4Global Initiative for Chronic Obstructive Pulmonary Disease.Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease,Available at www.goldcopd.com,2006
5Davies L,Angus RM,Calverley PM.Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease:a prospective randomized controlled trial.Lancet,1999,354(9177):456-460.
6National Institute for Clinical Excellence(NICE).Chronic obstructive pulmonary disease.National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary case.Thorax,2004,59(Suppl 1):1-232.
7Maltais F,Ostinali J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prodnisolone with placebo in the tratemtn of acute exacerbaions of chronic obstructive pulmonary disease:a randomized controlled trial.Am J Respir Crit Care Med,2002,165(5):698-703.
8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infectious.Eur Respir J,2005,26(6):1138-1180.
1Monso E, Rosell A, Boner G, et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J, 1999, 13:338 - 342
2Tom M, Wilkinson A,Iren S, et al. Airway Bacterial local and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Repir Crit Care Meal,2003,167:1090 - 1095
3Stockley RA, O' Brien C, Pye A, et al. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest,2001,117:1638 - 1645
4Noguera A, Battles S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax,2001,56:432 - 437
6Pauwels RA, Buist .AS, Calverley PM, et al. GOLD: the global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001,46 : 798 - 825
7Adams SG, Melo J, Luthe M, et al. Antibiotics are associated with lower relapse rates in ontpatients with acute exacerbatios of COPD. Chest. 2000, 117:1345 - 1352
8Aaron SD, Angel JB. Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive puhnonary disease. Am J Respir Crit Care Med 2001,163:349 - 355
9Sethi S, Murphy TF. Bacterial infection in chronic obstructive disease in 2000: a state-of-the-art review. Clin Microbiol Rev.2001,14:336 - 363
10Sohy C, Pilette C, Niederman MS, et al. Acute exacerbation of chronic obstructive pulmonary disease and antibiotics, what studies are still needed. Eur Respir J, 2002, 19:966 - 975
